PHIO
PhioBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-17
Current thesis
The constructive read is that PHIO has finished the clinical phase of PH-762 dose escalation, reported favorable safety/pathology framing, secured toxicology and U.S. cGMP supply agreements, and still guides to runway into H1 2027, leaving room for a meaningful re-rate if FDA feedback supports a credible next trial design [#PR-EARNINGS-2026-05-08].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Cash fell to about $17 million by March 31, 2026 and the April 2026 ATM adds dilution risk if external funding is needed sooner than hoped.
Momentum
87
Value
58
Sentiment
38
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.85 · Bull $1.80 · Bear $0.40
Data freshness
Prices
As of 2026-07-17
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-17 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-25 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-17
Investment thesis
As of 2026-07-17
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $14.00
Why
Momentum87 · Δ7d -
Value58 · Δ7d -0.2
Sentiment38 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
87
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
39% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-0.0
Sentiment
38
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 86.7 / Value 57.5 / Sentiment 38.0
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$11.97M
Beta
0.93
Shares Out
11.62M
P/E (TTM) · Derived
-0.7
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.72
Rev YoY
-100.0%
EPS YoY
-16.1%
Gross Margin
-
Op Margin
-
Net Debt
-$21.03M
Current Ratio
18.32
As of 2026-07-17 • Updated nightlySource: Internal modelMethodology